ACTICOAT^◊ Post-Op is an absorbent post-operative dressing consisting of the following:

• A Nanocrystalline silver-coated polyurethane layer 
• A white polyurethane foam pad
• An adhesive coated waterproof polyurethane film layer

ACTICOAT^◊ Post-Op provides an effective barrier to bacterial penetration. In the presence of exudate the dressing will help maintain a moist wound environment. ACTICOAT^◊ Post-Op may be left in place over a wound for up to 7 days.

ACTICOAT^◊ Post-Op Dressing is indicated for use in light to moderately exuding partial and full thickness wounds including decubitus ulcers, diabetic ulcers, surgical wounds, 1st and 2nd degree burns, and donor sites. ACTICOAT^◊ Post-Op dressing may be used over debrided and partial thickness wounds.

Contraindications

• Do not use on patients with a known sensitivity to silver
• Do not use on patients during MRI (Magnetic Resonance Imaging) examination
• Prior to commencing radiation therapy remove ACTICOAT^◊ Post-Op. A new dressing can be applied following treatment

Precautions

• For external use only
• ACTICOAT^◊ Post-Op is not compatible with oil-base products such as petrolatum
• ACTICOAT^◊ Post-Op may not be compatible with topical antimicrobials
• Do not use ACTICOAT^◊ Post-Op with saline
• ACTICOAT^◊ Post-Op is not compatible with oxidizing agents (eg. EUSOL) as these can break down the absorbent polyurethane component of the dressing
• Avoid contact with electrodes or conductive gels during electronic measurements eg. EEG and ECG
• ACTICOAT^◊ Post-Op Dressings are not intended to provide treatment for infected wounds
• ACTICOAT^◊ Post-Op Dressings may be used on infected wounds which are being managed in accordance with institutional clinical protocols for infection abatement as an adjunct to the standard treatment regimen to provide a barrier to bacterial infection
• As with all inappropriate use or too frequent dressing changes, particularly on patients with fragile skin, can result in skin stripping. If reddening or sensitization occur, discontinue use
• ACTICOAT^◊ Post-Op should only be used in premature infants (<3weeks gestation) when clinical benefit outweighs any potential patient risks

™SILCRYST is a Trademark of NUCRYST Pharmaceuticals Corp. used under license.